title: Pegylated interferon-associated retinopathy in chronic hepatitis C patients.
authors.forename: Hiroko
authors.initials: H
authors.lastname: Ogata
authors.forename: Hiromasa
authors.initials: H
authors.lastname: Suzuki
authors.forename: Kimiya
authors.initials: K
authors.lastname: Shimizu
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Ishikawa
authors.forename: Namiki
authors.initials: N
authors.lastname: Izumi
authors.forename: Masayuki
authors.initials: M
authors.lastname: Kurosaki
mesh_terms: D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004337:Drug Carriers; D005260:Female; D005500:Follow-Up Studies; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D015994:Incidence; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000009:adverse effects* / Q000627:therapeutic use; D011994:Recombinant Proteins; D012164:Retinal Diseases / Q000139:chemically induced* / Q000453:epidemiology
chemical_list: D000998:Antiviral Agents; D004337:Drug Carriers; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a